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Abstract
Dihydropyridine calcium channel blockers consist one of the widely-used groups of 
drugs for the management of hypertension. In this study, antihypertensive effects of 5 newly 
synthesized derivatives of DHP was examined the in rat model of two-kidney, one-clip renal 
hypertension. The results showed that those compounds containing two nitroxy groups had less 
decreasing effect on MAP (Men Arterial Pressure) compared to those having one nitroxy group 
in 5 position. On the other hand, conformational analysis indicated that in two compounds with 
two chains (A and E), a great steric hindrance existed; therefore, steric hindrance is the most 
important factor for interaction of compounds with their receptors. 
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Introduction
Since the introduction of dihydropyridine 
calcium channel blockers in 1970s (1), their 
clinical uses have been increasing. They have 
been widely used for various cardiovascular 
disorders including hypertension, angina 
pectoris, heart failure and Raynaud’s disease 
(2, 3).
Dihydropyridine calcium channel blockers 
are mainly vascular specific and act by inhibiting 
the influx of calcium ion into the vascular 
smooth muscle cells via L-type calcium channels 
(4). Their beneficial effects in cardiovascular 
disorders are due to their ability to relax vascular 
smooth muscles. In angina pectoris, such drugs 
produce resistance in systemic and coronary 
arterial beds thereby reducing cardiac oxygen 
requirement and increasing cardiac oxygen 
supply, respectively (5). 
The uses of dihydropyridine calcium channel 
blockers in hypertension were the subjects of 
a number of clinical trials. Dihydropyridine 
calcium channel blockers caused an equal 
incidence of fatal coronary heart diseases 
and nonfatal myocardial infarction, a lower 
incidence of stroke and a higher incidence 
of heart failure compared to those caused by 
angiotensin converting enzyme inhibitors (6). 
Meta-analysis of a number of clinical trials 
showed that the use of calcium channel blockers 
including dihydropyridine ones was associated 
with significant reductions in the risk of stroke, 
major cardiovascular events, and cardiovascular 
disease-related mortalities, but no significant 
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reductions in coronary heart disease, heart 
failure or total mortality (7). The findings of 
clinical trials such as that of ALLHAT led to 
the establishment of dihydropyridine calcium 
channel blockers as one of the main groups of 
drugs used for the treatment of hypertension.    
In our previous studies, we combined two 
antihypertensive approaches, Ca channel 
blocking using DHP derivatives fussed to nitroxy 
group to 3,5 positions as NO donor (8). The 
in vitro evaluation showed that they are more 
potent Ca channel blockers.
Therefore, the objective of the present study 
was to examine the antihypertensive effects of 
a number of 5 synthesized derivatives of DHP 
in rat model of two-kidney, one-clip renal 
hypertension.    
experimental
Drugs
Xylosine and ketamine were obtained 
from Alfasan Co, Holland. Sodium thiopental 
was obtained from Biochem Gmbh, Austria. 
Nifedipine was purchased from Sigma, USA. 
Compound A, B, C, D, and E were synthesized in 
the department of Medicinal Chemistry, School 
of Pharmacy, Shiraz University of Medical 
Sciences (Figure 1). Ketamine, xylosine and 
sodium thiopental were dissolved in normal 
saline. Nifedipine and compounds A, B, C, D, 
and E were dissolved in DMSO.
Induction of renal hypertension
Male Sprague-Dawley rats (200-250 g) were 
subjected to sham operation (n=5) or placement 
of a solid plexiglass clips (9) around left renal 
artery (n=5). Animals were anesthetized with 
intraperitoneal injections of 8 mg/kg xylosine 
(Alfasan, Holland) and 60 mg/kg ketamine 
(Alfasan, Holland). Through a left flank 
incision, the left kidneys were exposed, and left 
renal arteries were separated from renal vein 
and surrounding tissues. Afterwards, plexiglass 
clips were placed applied on the exposed renal 
arteries as close as possible to the aorta. Once 
placed over renal artery, the clip was turned 
so that the slit opening faced the abdomen to 
ensure that the renal artery remains within the 
clip.  Care was taken that the renal artery was 
placed deep in the clip slit, and that the flow of 
blood was visible down in the clip. The right 
kidney was not disturbed. Then antibiotic 
powder (Penicillin G) was applied to the site 
of incision, and abdominal wall and skin were 
sutured by absorbable chromic catgut and silk 
suture materials (Supa, Iran), respectively. 
Sham-operated animals were subjected to the 
same procedure, but clip was applied to the left 
renal artery. Animals were then recovered from 
anesthesia and kept two in a cage at 22-25°C 
and a light cycle of 12 h light/12 h darkness with 
food and water ad libitum. 
Experimental design
Animals were divided into sham and one renal 
artery clipped group. Then renal artery clipped 
rats were further divided into 7 groups (n = 5), 
and assigned to receive dimethylsulfoxide 
(DMSO, 0.05 mL) as vehicle, nifedipine, A, B, 
C, D, or E at 100, 300, or 1000 µg/kg.       
Experimental protocol
Four weeks after the operation, animals 
were anesthetized with diazepam (3 mg/kg) 
and sodium thiopental (70 mg/kg, ip). The 





















Figure 1. Chemical structure of nifedipine and 5 DHP 
derivatives used in this study.
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catheters (Polyethyleene Tubing, Becton 
Dickinson, USA) for supplying anesthetic as 
needed and injection of vehicle or drugs. The 
left external carotid arteries were cannulated 
for the measurement of blood pressure using 
a Gould Statham pressure transducer (Model 
P23D), connected to a Grass polygraph (Model 
7P1D). Animals were then allowed to recover 
for 30 min, and a measurement of blood 
pressure and heart rate was performed. The renal 
artery clipped rats were assigned to receive an 
intravenous injection of dimethylsulfoxide 
vehicle, nifedipine, or compounds A, B, C, D, 
or E. Twenty five min after administration of the 
vehicle or drugs, another measurement of blood 
pressure and heart rate was made. Animals 
were then sacrificed by a bolus of anesthetic, 
and heart as well as left and right kidney were 
removed and weighed.  
Calculations and statistical analysis 
Mean arterial pressure was calculated as 
diastolic arterial pressure plus one third of 
pulse pressure. Heart rate was counted from 
arterial pulse pressure upstroke. The changes 
in mean arterial pressure and heart rate were 
calculated as the percentages of their values 
prior to administration of vehicle or drugs. The 
weights of heart and left and right kidneys were 
calculated as percentages of body weight. The 
data, presented as mean ± SEM, were analyzed 
using one way analysis of variance (ANOVA). 
Where a significant difference was found with 
ANOVA, the source of difference was located 
using Duncan multiple range test. In cases that 
the data were not normally distributed, statistical 
analysis was performed using Kruskal-Wallis 
test followed by Dunn’s procedure for multiple 


















































































































































Figure 2. Decrease in mean arterial pressure (Mean ± SEM) by 
the administration of DMSO, nifedipine, or compound A, B, C, 
D, D, or E at 100 µg/kg.
Figure 3. Decrease in Heart rate (Mean ± SEM) by the 
administration of DMSO, nifedipine, or compound A, B, C, D, 
D, or E at 100 µg/kg.
Figure 4. Decrease in mean arterial pressure (Mean ± SEM) by 
the administration of DMSO, nifedipine, or compound A, B, C, 
D, D, or E at 300 µg/kg.
Figure 5. Decrease in Heart rate (Mean ± SEM) by the 
administration of DMSO, nifedipine, or compound A, B, C, D, 
D, or E at 300 µg/kg.
statistically significant. 
Conformation analysis
Chemical structure of each molecule was 
built by Hyperchem software for the structural 
chemistry (10). Gaussian98 program was 
operated to optimize the molecular structure 
(11). The structures were optimized by the RHF 
method of ab initio at the level of STO-3G. No 
molecular symmetry constraint was applied; 
rather full optimization of all bond lengths and 
angles was carried out. The root mean square 
of 0.1 kcal mol-1 was used as ending criteria 
in geometry optimization. Then, the molecules 
were reloaded to Hyperchem (12).
results
The renal artery clipped groups assigned 
to receive vehicle, nifedipine or new calcium 
channel blocker had significantly higher baseline 
mean arterial pressures compared to that of sham-
operated group (Table 1). However, there was no 
significant difference in the heart rate between 
such groups. Moreover, renal artery clipped 
groups had significantly higher right kidney and 
heart weights, and significantly lower left kidney 
weights compared to those of sham-operated 
group. In addition, there was no significant 
difference in the animals’ body weights on 
operation or experiment days between renal 
artery clipped or sham-operated rats (Table 1). 
Administration of vehicle (DMSO) did not 
make a significant difference in mean arterial 
pressure (169 ± 8 vs 171 ± 7 mmHg) or heart 
rate (420 ± 10 vs 424 ± 13 bpm). 
compared to the changes induced by the 
administration of DMSO; administration of 
nifedipine, or compounds B or A’ at 100 µg/kg 
















































































100 µg/kg administration day 300 µg/kg administration day 1000 µg/kg administration day
Mean weight± SD
Sham 209.2 ± 10.7 209.2 ± 10.7 209.2 ± 10.7
Vehicle 218.3 ± 12.9 218.3 ± 12.9 218.3 ± 12.9
Nifedipine 200.0 ± 11.5 211.2 ± 10.3 208.3 ± 6.8
A 199.2 ± 4.9 210.0 ± 14.1 205.0 ± 7.1
B 199.6 ± 9.9 217.5 ± 16.5 217.0 ± 15.2
C 207.8 ± 15.2 216.6 ± 18.0 211.0 ± 7.4
D 213.3 ± 16.6 213.7 ± 17.5 206.2 ± 4.8
E 207.5 ± 8.8 206.2 ± 7.5 219.0 ± 18.1
Figure 6. Decrease in mean arterial pressure (Mean ± SEM) by 
the administration of DMSO, nifedipine, or compound A, B, C, 
D, D, or E at 300 µg/kg.
Figure 7. Decrease in Heart rate (Mean ± SEM) by the 
administration of DMSO, nifedipine, or compound A, B, C, D, 
D, or E at 1000 µg/kg.
table 1. Animal’s body weights on operation or experiment days from renal artery clipped or sham-operated rats.
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pressure. However, compounds A, C, or E did not 
significantly change the mean arterial pressure 
from that of DMSO. There was no significant 
difference between the changes induced in mean 
arterial pressure by nifedipine, or compounds 
B, C, D whereas the reduction in mean arterial 
pressure by nifedipine was significantly more 
than those of compounds A or E (Figure 2). 
Moreover, there was no significant difference 
among the changes induced in the heart rate 
by the administration of DMSO, nifedipine, 
or compound A, B, C, D, or E at 100 µg/kg 
(Figure 3).  
Compared to the changes induced by the 
administration of DMSO, administration of 
nifedipine, or compounds B or D at 300 µg/kg 






pressure. However, compounds A, C, and D 
did not significantly change the mean arterial 
pressure from that of DMSO. There was no 
significant difference between the changes 
induced in mean arterial pressure by nifedipine 
and compounds B, C, or D whereas the reduction 
in mean arterial pressure by nifedipine was 
significantly more than those of compounds A or 
D (Figure 4). Moreover, there was no significant 
difference among the changes induced in the 
heart rate by the administration of DMSO, 
nifedipine, or compound A, B, C, D, or E at 300 
µg/kg (Figure 5). 
Relative to the changes induced by the 
administration of DMSO, administration of 
nifedipine, or compounds B, C, or D 1000 µg/kg 
caused a significant reduction in mean arterial 
Figure 8. Optimized structures of DHP derivatives.
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pressure. However, compounds A and E did not 
change the mean arterial pressure significantly 
different from that of DMSO. There was no 
significant difference between the changes 
induced in mean arterial pressure by nifedipine 
and compounds B, C or D. the reduction in mean 
arterial pressure by conpounds A, E and F were 
significantly less than that of nifedipine (Figure 
6). Moreover, there was no significant difference 
among the changes induced in the heart rate 
by the administration of DMSO, nifedipine, 
or compound A, B, C, D, or E at 1000 µg/kg. 
(Figure 7).
discussion
The findings of the present study showed 
that the placement of renal arterial clips around 
left renal artery, while leaving the right kidney 
intact, did result in hypertension characterized 
by increased mean arterial pressure as well as 
increased heart and right kidney weights and 
decreased left kidney weight. Two-kidney, one-
clip or Goldblatt renal hypertension has been 
produced using silver clips. We showed that 
the placement of solid plexiglass clips around 
left kidney was associated with a hypertension 
comparable to that induced by silver clips (9). 
The values of blood pressure in hypertensive 
rats in the present study were within the range 
of those induced by silver clips. Moreover, the 
values of heart and left and right kidney weights 
were comparable to those reported previously 
(9).
From the SAR viewpoint, we expected that 
those compounds containing two nitroxy groups 
had more decreasing effect on MAP, since it was 
supposed that nitroxy group can act as NO donor 
which resulted in more decrease in MAP and 
also the in vitro results sugest that the presence 
of nitroxy group can result in greater Ca channel 
blocking effect. However, % decrease in MAP 
showed the exact opposite results i.e. the one 
chain compounds (B, C and D) in 5 position had 
more decreasing effect.
On the other hand, conformation analysis 
(Figure 8) indicated that in two compounds with 
two chains (A and E), a great steric hindrance 
existed, since there was an angle of more than 90° 
between two chains while in other compounds, 
which have one chain, such hindrance did not 
occur.
Therefore, it can be concluded that 5 position 
had a great impact on antihypertensive ability 
of these DHP derivatives and also the possible 
interaction with Ca channels. Furthermore, 
presence of nitroxy group does not affect the 
activity, since there is no sign of decrease in 
MAP compared to reference drug (Nifedipine) 
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